Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: A Cancer and Leukemia Group B Study

Blood

Volumn 90, Issue 11, 1997, Pages 4532-4538

  Mrózek, Krzysztof ^a   Heinonen, Kristiina ^b   Lawrence, David ^b   Carroll, Andrew J ^b   Koduru, Prasad R K ^b   Rao, Kathleen W ^b   Strout, Matthew P ^b   Hutchison, Robert E ^b   Moore, Joseph O ^b   Mayer, Robert J ^b   Schiffer, Charles A ^b   Bloomfield, Clara D ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11Q; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; GENE INSERTION; GENE REARRANGEMENT; HUMAN; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; REMISSION;

EID: 1842289846     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.11.4532.4532_4532_4538     Document Type: Article

References (41)

1. Bloomfield CD, de la Chapelle A: Chromosome abnormalities in acute nonlymphocytic leukemia: Clinical and biologic significance. Semin Oncol 14:372, 1987
2. Arthur DC, Berger R, Golomb HM, Swansbury GJ, Reeves BR, Alimena G, Van Den Berghe H, Bloomfield CD, de la Chapelle A, Dewald GW, Garson OM, Hagemeijer A, Kaneko Y, Mitelman F, Pierre RV, Ruutu T, Sakurai M, Lawler SD, Rowley JD: The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet 40:203, 1989
3. Mrózek K, Heinonen K, de la Chapelle A, Bloomfield CD: Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 24:17, 1997
4. Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ: Cytogenetic pattern in acute myelogenous leukemia: A major reproducible determinant of outcome. Leukemia 2:403, 1988
5. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR: Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 73:263, 1989
6. Marosi C, Köller U, Koller-Weber E, Schwarzinger I, Schneider B, Jäger U, Vahls P, Nowotny H, Pirc-Danoewinata H, Steger G, Kreiner G, Wagner B, Lechner K, Lutz D, Bettelheim P, Haas OA: Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Cancer Genet Cytogenet 61:14, 1992
7. Stasi R, Del Poeta G, Masi M, Tribalto M, Venditti A, Papa G, Nicoletti B, Vernole P, Tedeschi B, Delaroche I, Mingarelli R, Dallapiccola B: Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia. Cancer Genet Cytogenet 67:28, 1993
8. Cortes J, O'Brien S, Kantarjian H, Cork A, Stass S, Freireich EJ, Keating MJ, Pierce S, Estey E: Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes. Leukemia 8:2174, 1994
9. Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F, Stoppa A-M, Marit G, Molina L, Michallet M, Maraninchi D, Attal M, Reiffers J, for the BGMT group: Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia 9:1491, 1995
10. Fenaux P, Preudhomme C, Laï JL, Morel P, Beuscart R, Bauters F: Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: A report on 283 cases. Br J Haematol 73:61, 1989
11. Joventino LP, Stock W, Lane NJ, Daly KM, Mick R, Le Beau MM, Larson RA: Certain HLA antigens are associated with specific morphologic and cytogenetic subsets of acute myeloid leukemia. Leukemia 9:433, 1995
12. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R III, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD, Diaz MO: Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88:10735, 1991
13. Cimino G, Moir DT, Canaani O, Williams K, Crist WM, Katzav S, Cannizzaro L, Lange B, Nowell PC, Croce CM, Canaani E: Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res 51:6712, 1991
14. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691, 1992
15. Djabali M, Selleri L, Parry P, Bower M, Young BD, Evans GA: A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat Genet 2:113, 1992
16. Mitelman F, Kaneko Y, Berger R: Report of the committee on chromosome changes in neoplasia, in Cuticchia AJ, Chipperfield MA, Foster PA (eds): Human Gene Mapping 1995. A Compendium. Baltimore, MD, Johns Hopkins University Press, 1996, p 1332
17. Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, DeBlasio A, Miller WH Jr, Zelenetz AD, Willman CL, Chen Z, Chen S-J, Zelent A, Macintyre E, Veil A, Cortes J, Kantarjian H, Waxman S: Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85:1083, 1995
18. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, Le Beau MM, Diaz MO, Rowley JD: Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329:909, 1993
19. Young BD: The molecular analysis of I1q23 abnormalities in leukemia, in McArthur JR, Lee SH, Wong JEL, Ong YW (eds): Haematology 1996: Education Programme of the 26th Congress of the International Society of Haematology, Singapore, August 25-29, 1996. Singapore, International Society of Haematology, 1996, p 369
20. Kalwinski DK, Raimondi SC, Schell MJ, Mirro J Jr, Santana VM, Behm F, Dahl GV, Williams D: Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 8:75, 1990
21. Martinez-Climent JA, Espinosa R III, Thirman MJ, Le Beau MM, Rowley JD: Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival. J Pediatr Hematol Oncol 17:277, 1995
22. Leblanc T, Auvrignon A, Michel G, Ansoborlo S, van den Akker J, Nelken B, Capodano A-M, Landman-Parker J, Baruchel A, Berger R, Schaison G, Leverger G: Prognosis value of cytogenetics in 250 children with acute myeloblastic leukemia treated in the LAME 89/91 protocol. Blood 88:634a, 1996 (suppl 1, abstr)
23. Döhner H, Arthur DC, Ball ED, Sobol RE, Davey FR, Lawrence D, Gordon L, Patil SR, Surana RB, Testa JR, Verma RS, Schiffer CA, Wurster-Hill DH, Bloomfield CD: Trisomy 13: A new recurring chromosome abnormality in acute leukemia. Blood 76:1614, 1990
24. Mayer RJ, Schiffer CA, Peterson BA, Silver RT, Cornwell, GG, McIntyre OR, Rai KR, Budman DR, Ellison RR, Maguire M, Davis RB, Frei E III: Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: Preliminary results of a CALGB phase I study. Semin Oncol 12:84, 1985 (suppl 3)
25. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E III, for the Cancer and Leukemia Group B: Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896, 1994
26. Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schiffer CA, for the Cancer and Leukemia Group B: Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. N Engl J Med 332:1671, 1995
27. Moore JO, Dodge RK, Amrein PC, Kolitz J, Lee EJ, Powell B, Godfrey S, Robert F, Schiffer CA: Granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022. Blood 89:780, 1997
28. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:620, 1985
29. Hamblin TJ, Oscier DG: The myelodysplastic syndrome - A practical guide. Hematol Oncol 5:19, 1987
30. Kouides PA, Bennett JM: Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin Hematol 33:95, 1996
31. Mitelman F (ed): ISCN (1995): An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
32. Kaplan EL, Meier P: Nonparametric estimations from incomplete observations. J Am Stat Assoc 53:457, 1958
33. Fleming TR, O'Fallon JR, O'Brien PC, Harrington DP: Modified Kolmogorov-Smirnov test procedures with application to arbitrarily right-censored data. Biometrics 36:607, 1980
34. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML: HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 81:3197, 1993
35. Marukawa O, Akao Y, Inazawa J, Ariyama T, Abe T, Naoe T, Tanimoto M, Saito H, Otsuki Y, Tsujimoto Y: Molecular cloning of the breakpoint of t(11;22)(q23;q11) chromosome translocation in an adult acute myelomonocytic leukaemia. Br J Haematol 92:687, 1996
36. Bower M, Parry P, Carter M, Lillington DM, Amess J, Lister TA, Evans G, Young BD: Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. Blood 84:3776, 1994
37. Cimino G, Rapanotti MC, Elia L, Biondi A, Fizzotti M, Testi AM, Tosti S, Croce CM, Canaani E, Mandelli F, Lo Coco F: ALL-1 gene rearrangements in acute myeloid leukemia: Association with M4-M5 French-American-British classification subtypes and young age. Cancer Res 55:1625, 1995
38. Mitelman F: Catalog of Chromosome Aberrations in Cancer (ed 5). New York, NY, Wiley-Liss, 1994
39. Mrózek K, Bloomfield CD: Chromosome aberrations, in Bertino JR (ed): Encyclopedia of Cancer (vol I). San Diego, CA, Academic, 1997, p 380
40. Slack JL, Arthur DC, Lawrence D, Mrózek K, Mayer RJ, Davey FR, Tantravahi R, Pettenati MJ, Bigner S, Carroll AJ, Rao KW, Schiffer CA, Bloomfield CD: Secondary cytogenetic changes in acute promyelocytic leukemia: Prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene. A Cancer and Leukemia Group B study. J Clin Oncol 15:1786, 1997
41. Kalwinski D, Mirro J Jr, Schell MJ, Behm F, Mason C, Dahl GV: Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: Improved remission induction with a five-drug regimen including etoposide. J Clin Oncol 6:1134, 1988